PP
LSTA icon

Paloma Partners’s Lisata Therapeutics LSTA Stock Holding History

Paloma Partners’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-269
Closed -$75K – 1781
2015
Q2 		$75K Buy
269
+156
+138% +$58K ﹤0.01% 1708
2015
Q1 		$43K Buy
+113
New +$61.3K ﹤0.01% 1149
2013
Q4 		– Sell
-73
Closed -$94K – 1103
2013
Q3 		$94K Buy
+73
New +$81.1K ﹤0.01% 849

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Paloma Partners's LSTA Position: Q3 2015 in Review

Paloma Partners sold out of Lisata Therapeutics (LSTA) in Q3 2015, closing a stake of 269 shares — an estimated $75K sold.

Paloma Partners first reported a position in LSTA in Q3 2013 and held it in 3 quarters. The position peaked at $94K in Q3 2013. 43 funds tracked by Wall St. Rank hold LSTA as of Q3 2015.

  • Paloma Partners reported no remaining Lisata Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Paloma Partners sold 269 Lisata Therapeutics shares in Q3 2015, an estimated $75K.
  • Paloma Partners first reported a position in Lisata Therapeutics in Q3 2013 and held it in 3 quarters.
  • Paloma Partners's Lisata Therapeutics position peaked at $94K in Q3 2013.
  • 43 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2015.

Based on Paloma Partners's 13F filing for Q3 2015, filed 16 Nov 2015.